ZL0420 is primarily utilized in the field of biomedical research, particularly in the study of neurodegenerative diseases. It has shown potential as a therapeutic agent for conditions like Alzheimer's disease due to its ability to modulate specific pathways involved in neuronal protection and inflammation. Researchers are exploring its efficacy in reducing amyloid-beta plaques and tau protein aggregation, which are hallmark features of Alzheimer's. Additionally, ZL0420 is being investigated for its neuroprotective properties in models of Parkinson's disease and other cognitive disorders. Its application extends to preclinical studies, where it aids in understanding the mechanisms of neuroprotection and developing potential treatments for neurological conditions.